183 related articles for article (PubMed ID: 32219444)
1. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Gang EJ; Kim HN; Hsieh YT; Ruan Y; Ogana HA; Lee S; Pham J; Geng H; Park E; Klemm L; Willman CL; Carroll WL; Mittelman SD; Orgel E; Oberley MJ; Parekh C; Abdel-Azim H; Bhojwani D; Wayne AS; De Arcangelis A; Georges-Labouesse E; Wayner E; Bonig H; Minasyan A; Ten Hoeve J; Graeber TG; Müschen M; Heisterkamp N; Kim YM
Blood; 2020 Jul; 136(2):210-223. PubMed ID: 32219444
[TBL] [Abstract][Full Text] [Related]
2. Involvement of BCR::ABL1 in laminin adhesion of Philadelphia chromosome-positive acute lymphoblastic leukemia through upregulation of integrin α6.
Takahashi K; Nguyen TTT; Watanabe A; Sato H; Saito K; Tamai M; Harama D; Kasai S; Akahane K; Goi K; Kagami K; Abe M; Komatsu C; Maeda Y; Sugita K; Inukai T
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2034. PubMed ID: 38577721
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3K/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2.
Ding J; Romani J; Zaborski M; MacLeod RA; Nagel S; Drexler HG; Quentmeier H
PLoS One; 2013; 8(12):e83510. PubMed ID: 24349524
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Hsieh YT; Gang EJ; Geng H; Park E; Huantes S; Chudziak D; Dauber K; Schaefer P; Scharman C; Shimada H; Shojaee S; Klemm L; Parameswaran R; Loh M; Kang ES; Koo HH; Hofmann WK; Andrade J; Crooks GM; Willman CL; Müschen M; Papayannopoulou T; Heisterkamp N; Bönig H; Kim YM
Blood; 2013 Mar; 121(10):1814-8. PubMed ID: 23319569
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.
Germain M; De Arcangelis A; Robinson SD; Baker M; Tavora B; D'Amico G; Silva R; Kostourou V; Reynolds LE; Watson A; Jones JL; Georges-Labouesse E; Hodivala-Dilke K
J Pathol; 2010 Feb; 220(3):370-81. PubMed ID: 19967723
[TBL] [Abstract][Full Text] [Related]
6. The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
Yamakawa N; Kaneda K; Saito Y; Ichihara E; Morishita K
PLoS One; 2012; 7(1):e30706. PubMed ID: 22295105
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.
Satake N; Duong C; Chen C; Barisone GA; Diaz E; Tuscano J; Rocke DM; Nolta J; Nitin N
Br J Haematol; 2014 Nov; 167(4):487-99. PubMed ID: 25196579
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
[TBL] [Abstract][Full Text] [Related]
10. The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line.
Villegas-Pineda JC; Toledo-Leyva A; Osorio-Trujillo JC; Hernández-Ramírez VI; Talamás-Rohana P
Exp Cell Res; 2017 Feb; 351(2):127-134. PubMed ID: 28131812
[TBL] [Abstract][Full Text] [Related]
11. α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation.
Basu S; Rajakaruna S; De Arcangelis A; Zhang L; Georges-Labouesse E; Menko AS
J Biol Chem; 2014 Feb; 289(7):3842-55. PubMed ID: 24381169
[TBL] [Abstract][Full Text] [Related]
12. Integrin Antibody Decreases Deformability of Patient-Derived Pre-B Acute Lymphocytic Leukemia Cells as Measured by High-Frequency Acoustic Tweezers.
Liu HC; Gang EJ; Kim HN; Abdel-Azim N; Chen R; Abdel-Azim H; Shung KK; Kim YM
J Ultrasound Med; 2020 Mar; 39(3):589-595. PubMed ID: 31633840
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging.
Liu HC; Gang EJ; Kim HN; Ruan Y; Ogana H; Wan Z; Bönig H; Shung KK; Kim YM
Cells; 2020 Jun; 9(6):. PubMed ID: 32560076
[TBL] [Abstract][Full Text] [Related]
14. Leukaemia hijacks a neural mechanism to invade the central nervous system.
Yao H; Price TT; Cantelli G; Ngo B; Warner MJ; Olivere L; Ridge SM; Jablonski EM; Therrien J; Tannheimer S; McCall CM; Chenn A; Sipkins DA
Nature; 2018 Aug; 560(7716):55-60. PubMed ID: 30022166
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition.
Xiao X; Liu P; Li D; Xia Z; Wang P; Zhang X; Liu M; Liao L; Jiao B; Ren R
J Hematol Oncol; 2020 Jun; 13(1):80. PubMed ID: 32552902
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of integrins alpha6 and alpha4 in homing of fetal liver hematopoietic stem and progenitor cells.
Qian H; Georges-Labouesse E; Nyström A; Domogatskaya A; Tryggvason K; Jacobsen SE; Ekblom M
Blood; 2007 Oct; 110(7):2399-407. PubMed ID: 17586725
[TBL] [Abstract][Full Text] [Related]
17. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
[TBL] [Abstract][Full Text] [Related]
18. [Central nervous system involvement in acute lymphoblastic leukemia].
Yao H
Rinsho Ketsueki; 2019; 60(9):1212-1220. PubMed ID: 31597846
[TBL] [Abstract][Full Text] [Related]
19. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
20. CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.
Collins K; Cardinali JL; Mnayer LO; DiGiuseppe JA
Cytometry B Clin Cytom; 2021 Mar; 100(2):243-248. PubMed ID: 31894899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
